Add-on Acquisition • Life Science

Biotie Therapies Acquires elbion NV

On October 27, 2008, Biotie Therapies acquired life science company elbion NV

Acquisition Context

This is Biotie Therapies’ 1st transaction in the Life Science sector.
This is Biotie Therapies’ 1st transaction in Belgium.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	October 27, 2008
Target	elbion NV
Sector	Life Science
Buyer(s)	Biotie Therapies
Deal Type	Add-on Acquisition

Target Company

elbion NV

Leuven, Belgium

elbion NV is a drug company focused on neurology and immunology.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Biotie Therapies

Turku, Finland

Category	Company
Sector	Life Science
Employees	39
Revenue	15M EUR (2014)

DESCRIPTION

Biotie Therapies Corp. is a biopharmaceutical company primarily focused on developing therapeutics for central nervous system disorders. Its pipeline includes product candidates designed to address unmet medical needs in Parkinson’s disease and related dementia, other neurodegenerative indications and primary sclerosing cholangitis, an orphan fibrotic liver disease.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Belgium	1 of 1
Year: 2008	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Belgium M&A - 2008 M&A